According to Fig. 8, compared with the DCM group, Cilostazol administration significantly decreased spinal levels of IL-1β (1.35 ± 0.17), cleaved-Caspase-1 (1.91 ± 0.25) and NLRP3 (2.77 ± 0.21), the western blot results were consistent with the immunohistochemistry. This evidence concerns the gene CASP1 and familial dilated cardiomyopathy.